|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0009566,
umls-concept:C0011847,
umls-concept:C0011854,
umls-concept:C0030705,
umls-concept:C0035309,
umls-concept:C0035647,
umls-concept:C0087111,
umls-concept:C0332307,
umls-concept:C0439234,
umls-concept:C0439590,
umls-concept:C1280500,
umls-concept:C2587213
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2008-12-9
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To examine the persistence of the original treatment effects 10 years after the Diabetes Control and Complications Trial (DCCT) in the follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study. In the DCCT, intensive therapy aimed at near-normal glycemia reduced the risk of microvascular complications of type 1 diabetes mellitus compared with conventional therapy.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-10102706,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-10333910,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-10666428,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-1420849,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-14570951,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-15684277,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-16249432,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-16371630,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-16443884,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-19273799,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-2062515,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-2866759,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-3556280,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-7622004,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-7734740,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-7826293,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-8139257,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-8366922,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19064853-9682700
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1538-3601
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
126
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1707-15
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19064853-Adolescent,
pubmed-meshheading:19064853-Adult,
pubmed-meshheading:19064853-Blood Glucose,
pubmed-meshheading:19064853-Diabetes Mellitus, Type 1,
pubmed-meshheading:19064853-Diabetic Retinopathy,
pubmed-meshheading:19064853-Disease Progression,
pubmed-meshheading:19064853-Female,
pubmed-meshheading:19064853-Follow-Up Studies,
pubmed-meshheading:19064853-Hemoglobin A, Glycosylated,
pubmed-meshheading:19064853-Humans,
pubmed-meshheading:19064853-Hypoglycemic Agents,
pubmed-meshheading:19064853-Incidence,
pubmed-meshheading:19064853-Infusion Pumps,
pubmed-meshheading:19064853-Insulin,
pubmed-meshheading:19064853-Male,
pubmed-meshheading:19064853-Prevalence,
pubmed-meshheading:19064853-Risk Factors,
pubmed-meshheading:19064853-Young Adult
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
|
|
pubmed:affiliation |
Diabetes Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
